ArticleFrontiers in oncology2022

Circulating Tumor DNA in Identifying Resistant Sub-Clones Post EGFR Blockade: Implications for EGFR Rechallenge.

Adithya Chennamadhavuni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.